← 返回

间皮素靶向 CAR.CIK 淋巴细胞对抗卵巢癌腹膜癌病的三维动力学

英文原题:Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

查看英文原题

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

PubMed 2024/11/02(内容时间) Cancer Immunol Immunother Q1 · IF 5.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

腹腔内细胞免疫治疗采用CAR重定向淋巴细胞是一种针对卵巢癌(OC)腹膜癌病(PC)的有前景的方法,目前正在临床试验中进行评估。PC呈现复合结构,腹水中有漂浮的肿瘤细胞,同时有类似实体的肿块侵入腹膜。

因此,一个全面的实验模型对于在这种特殊环境中优化CAR细胞疗法至关重要。在此,我们探索了经CAR重定向针对间皮素(MSLN-CAR.CIK)的细胞因子诱导杀伤淋巴细胞(CIK)在还原性3D模型中的活性,这些模型模拟了PC液体和固体组分的结构复杂性。MSLN-CAR.CIK有效杀伤并对OC靶标具有功能效率。在具有漂浮OC球体的“漂浮样”3D环境中,MSLN-CAR.CIK的肿瘤定位和杀伤均被流体流动显著增强。在“实体样”环境中,MSLN-CAR.CIK通过细胞外基质被募集到嵌入的肿瘤聚集体上,其动力学因效应靶标距离而异。

此外,MSLN-CAR.CIK穿透OC球体的内部层次,发挥有效的肿瘤杀伤作用。我们的发现提供了目前未知的关于CAR.CIK腹腔内方法的治疗相关新信息,支持在OC来源PC患者局部区域细胞治疗方法的背景下进一步发展和改进临床研究。

展开英文摘要原文

Intraperitoneal cellular immunotherapy with CAR-redirected lymphocytes is an intriguing approach to target peritoneal carcinomatosis (PC) from ovarian cancer (OC), which is currently evaluated in clinical trials. PC displays a composite structure with floating tumor cells within ascites and solid-like masses invading the peritoneum.

Therefore, a comprehensive experimental model is crucial to optimize CAR-cell therapies in such a peculiar environment.

Here, we explored the activity of cytokine-induced killer lymphocytes (CIK), redirected by CAR against mesothelin (MSLN-CAR. CIK), within reductionistic 3D models resembling the structural complexity of both liquid and solid components of PC. MSLN-CAR. CIK effectively killed and were functionally efficient against OC targets.

In a "floating-like" 3D context with floating OC spheroids, both tumor localization and killing by MSLN-CAR. CIK were significantly boosted by fluid flow. In a "solid-like" context, MSLN-CAR. CIK were recruited through the extracellular matrix on embedded tumor aggregates, with variable kinetics depending on the effector-target distance.

Furthermore, MSLN-CAR. CIK penetrated the inner levels of OC spheroids exerting effective tumor killing.

Our findings provide currently unknown therapeutically relevant information on intraperitoneal approaches with CAR. CIK, supporting further developments and improvements for clinical studies in the context of locoregional cell therapy approaches for patients with PC from OC.

论文信息

作者
Galvagno F、Leuci V、Massa A、Donini C、Rotolo R、Capellero S、Proment A、Vitali L
第一作者单位
Department of Oncology, University of Torino, Turin, Italy.Italy
通讯作者单位
Department of Oncology, University of Torino, Turin, Italy. dario.sangiolo@unito.it.Italy
期刊
Cancer immunology, immunotherapy : CII2024 Nov 2
原文标识
PubMed 39487859 · DOI 10.1007/s00262-024-03860-w